Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Oizumi, Ami ^a,b   Nakayama, Hitoshi ^a,c   Okino, Nozomu ^d   Iwahara, Chihiro ^a   Kina, Katsunari ^a   Matsumoto, Ryo ^a   Ogawa, Hideoki ^a   Takamori, Kenji ^a,b   Ito, Makoto ^d   Suga, Yasushi ^b   Iwabuchi, Kazuhisa ^a,c  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; AUTACOID; CURCUMIN; ENDOTHELIN 1; I KAPPA B ALPHA; INFLIXIMAB; INTERLEUKIN 8; MESSENGER RNA; NEUTRAL CERAMIDASE; PSEUDOMONAS AERUGINOSA DERIVED NEUTRAL CERAMIDASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; TRITON X 100; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; I KAPPA B; LYSOPHOSPHOLIPID; NF-KAPPAB INHIBITOR ALPHA; PHOSPHOTRANSFERASE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MICROARRAY ANALYSIS; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRATUM CORNEUM; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CELL CULTURE; METABOLISM; PSEUDOMONAS;

CELLS, CULTURED; ENDOTHELIN-1; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; KERATINOCYTES; LYSOPHOSPHOLIPIDS; NEUTRAL CERAMIDASE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PSEUDOMONAS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896077471     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089402     Document Type: Article

References (66)

1. Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361: 151-160. (Pubitemid 36092023)
2. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, et al. (2009) Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 129: 1892-1908.
3. Beck LA, Leung DY (2000) Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol 106: S258-S263.
4. Watt FM, Hogan BL (2000) Out of Eden: stem cells and their niches. Science 287: 1427-1430. (Pubitemid 30127126)
5. Lampe MA, Williams ML, Elias PM (1983) Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 24: 131-140. (Pubitemid 13080346)
6. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, et al. (2002) Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119: 416-423. (Pubitemid 35001952)
7. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, et al. (2000) Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 114: 185-192. (Pubitemid 30195993)
8. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, et al. (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96: 523-526.
9. Leung DY (2003) Infection in atopic dermatitis. Curr Opin Pediatr 15: 399-404.
10. Sator PG, Schmidt JB, Honigsmann H (2003) Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 48: 352-358. (Pubitemid 36337071)
11. Ohnishi Y, Okino N, Ito M, Imayama S (1999) Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 6: 101-104. (Pubitemid 29035648)
12. Okino N, Tani M, Imayama S, Ito M (1998) Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 273: 14368-14373. (Pubitemid 28319154)
13. Kita K, Sueyoshi N, Okino N, Inagaki M, Ishida H, et al. (2002) Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase. Biochem J 362: 619-626. (Pubitemid 34242312)
14. Xia P, Wadham C (2011) Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. Cytokine Growth Factor Rev 22: 45-53.
15. Herzinger T, Kleuser B, Schafer-Korting M, Korting HC (2007) Sphingosine-1-phosphate signaling and the skin. Am J Clin Dermatol 8: 329-336. (Pubitemid 350174535)
16. Japtok L, Schaper K, Baumer W, Radeke HH, Jeong SK, et al. (2012) Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P(2) receptor subtype. PLoS One 7: e49427.
17. Reines I, Kietzmann M, Mischke R, Tschernig T, Luth A, et al. (2009) Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol 129: 1954-1962.
18. Sugita K, Kabashima K, Sakabe J, Yoshiki R, Tanizaki H, et al. (2010) FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in mice. Am J Pathol 177: 1881-1887.
19. Park K, Elias PM, Shin KO, Lee YM, Hupe M, et al. (2013) A novel role of lipid species, sphingosine-1-phosphate, in epithelial innate immunity. Mol Cell Biol 33: 752-762.
20. Uchida Y, Houben E, Park K, Douangpanya S, Lee YM, et al. (2010) Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB. J Invest Dermatol 130: 2472-2480.
21. Spoler F, Forst M, Marquardt Y, Hoeller D, Kurz H, et al. (2006) High-resolution optical coherence tomography as a non-destructive monitoring tool for the engineering of skin equivalents. Skin Res Technol 12: 261-267. (Pubitemid 44515673)
22. Inoue T, Okino N, Kakuta Y, Hijikata A, Okano H, et al. (2009) Mechanistic insights into the hydrolysis and synthesis of ceramide by neutral ceramidase. J Biol Chem 284: 9566-9577.
23. Katoh M, Hamajima F, Ogasawara T, Hata K (2009) Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol. J Toxicol Sci 34: 327-334.
24. Noborio R, Morita A (2010) Preferential induction of endothelin-1 in a human epidermal equivalent model by narrow-band ultraviolet B light sources. Photodermatol Photoimmunol Photomed 26: 159-161.
25. Spiekstra SW, Dos Santos GG, Scheper RJ, Gibbs S (2009) Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol In Vitro 23: 349-355.
26. Park T, Yi SG, Kang SH, Lee S, Lee YS, et al. (2003) Evaluation of normalization methods for microarray data. BMC Bioinformatics 4: 33.
27. Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM (2002) Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 303: 167-175.
28. He X, Dagan A, Gatt S, Schuchman EH (2005) Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3- dicarboxyaldehyde derivatization after hydrolysis with ceramidase. Anal Biochem 340: 113-122. (Pubitemid 40404107)
29. Janjetovic Z, Zmijewski MA, Tuckey RC, DeLeon DA, Nguyen MN, et al. (2009) 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 4: e5988.
30. Nakayama H, Yoshizaki F, Prinetti A, Sonnino S, Mauri L, et al. (2008) Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J Leukoc Biol 83: 728-741. (Pubitemid 351966883)
31. Voegeli TS, Currie RW (2009) siRNA knocks down Hsp27 and increases angiotensin II-induced phosphorylated NF-kappaB p65 levels in aortic smooth muscle cells. Inflamm Res 58: 336-343.
32. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, et al. (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172: 1609-1614.
33. Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242: 233-246.
34. Kato T, Takai T, Fujimura T, Matsuoka H, Ogawa T, et al. (2009) Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes. Allergy 64: 1366-1374.
35. Kita K, Okino N, Ito M (2000) Reverse hydrolysis reaction of a recombinant alkaline ceramidase of Pseudomonas aeruginosa. Biochim Biophys Acta 1485: 111-120. (Pubitemid 30314729)
36. van Ruissen F, Le M, Carroll JM, van der Valk PG, Schalkwijk J (1998) Differential effects of detergents on keratinocyte gene expression. J Invest Dermatol 110: 358-363. (Pubitemid 28158650)
37. Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, et al. (2004) Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem 279: 38471-38479. (Pubitemid 39295999)
38. Fujita H, Shemer A, Suarez-Farinas M, Johnson-Huang LM, Tintle S, et al. (2011) Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol 128: 574-582.
39. Kirschner N, Poetzl C, von den Driesch P, Wladykowski E, Moll I, et al. (2009) Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol 175: 1095-1106.
40. Lin YT, Wang CT, Chiang BL (2007) Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol 33: 167-177.
41. Sun J, Han J, Zhao Y, Zhu Q, Hu J (2012) Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Int Immunopharmacol 13: 170-174.
42. Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR (1999) Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem 274: 787-794.
43. Maniatis T (1997) Catalysis by a multiprotein IkappaB kinase complex. Science 278: 818-819.
44. Ahn GY, Butt KI, Jindo T, Yaguchi H, Tsuboi R, et al. (1998) The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J Dermatol 25: 78-84. (Pubitemid 28149924)
45. Lee CS, Ko HH, Seo SJ, Choi YW, Lee MW, et al. (2009) Diarylheptanoid hirsutenone prevents tumor necrosis factor-alpha-stimulated production of inflammatory mediators in human keratinocytes through NF-kappaB inhibition. Int Immunopharmacol 9: 1097-1104.
46. Lisby S, Faurschou A, Gniadecki R (2007) The autocrine TNFalpha signalling loop in keratinocytes requires atypical PKC species and NF-kappaB activation but is independent of cholesterol-enriched membrane microdomains. Biochem Pharmacol 73: 526-533. (Pubitemid 46038860)
47. Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, et al. (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175: 2721-2729. (Pubitemid 41113889)
48. Li CM, Hong SB, Kopal G, He X, Linke T, et al. (1998) Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase. Genomics 50: 267-274. (Pubitemid 28303521)
49. Chi H (2011) Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci 32: 16-24.
50. Siehler S, Wang Y, Fan X, Windh RT, Manning DR (2001) Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J Biol Chem 276: 48733-48739.
51. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, et al. (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465: 1084-1088.
52. Davis MD, Clemens JJ, Macdonald TL, Lynch KR (2005) Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 280: 9833-9841. (Pubitemid 40395829)
53. Walling HW, Swick BL (2010) Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol 3: 99-117.
54. Torii H, Nakagawa H; Japanese Infliximab Study Investigators (2011) Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma. J Dermatol 38: 321-334.
55. Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, et al. (2012) Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Br J Dermatol 166: 491-497.
56. Rigopoulos D, Korfitis C, Gregoriou S, Katsambas AD (2008) Infliximab in dermatological treatment: beyond psoriasis. Expert Opin Biol Ther 8: 123-133. (Pubitemid 351242511)
57. Ricci G, Dondi A, Patrizi A, Masi M (2009) Systemic therapy of atopic dermatitis in children. Drugs 69: 297-306.
58. Barker JN, Jones ML, Mitra RS, Crockett-Torabe E, Fantone JC, et al. (1991) Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139: 869-876.
59. Amarbayasgalan T, Takahashi H, Dekio I, Morita E (2013) Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int Arch Allergy Immunol 160: 63-74.
60. Kalish H, Phillips TM (2012) Assessment of chemokine profiles in human skin biopsies by an immunoaffinity capillary electrophoresis chip. Methods 56: 198-203.
61. Ghazvini P, Pagan LC, Rutledge TK, Goodman HS Jr (2010) Atopic dermatitis. J Pharm Pract 23: 110-116.
62. Ferreira SH, Romitelli M, de Nucci G (1989) Endothelin-1 participation in overt and inflammatory pain. J Cardiovasc Pharmacol 13 Suppl 5: S220-S222. (Pubitemid 19119256)
63. Katugampola R, Church MK, Clough GF (2000) The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Exp Physiol 85: 839-846.
64. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, et al. (2009) TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A 106: 11330-11335.
65. Houben E, Holleran WM, Yaginuma T, Mao C, Obeid LM, et al. (2006) Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis. J Lipid Res 47: 1063-1070. (Pubitemid 43764702)
66. Cho JW, Lee KS, Kim CW (2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19: 469-474.